433 related articles for article (PubMed ID: 28707482)
1. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.
Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM
ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.
Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM
Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676
[TBL] [Abstract][Full Text] [Related]
3. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
4. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
[TBL] [Abstract][Full Text] [Related]
5. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
[TBL] [Abstract][Full Text] [Related]
7. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.
Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ
J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451
[TBL] [Abstract][Full Text] [Related]
8. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease.
Lin AL; Parikh I; Yanckello LM; White RS; Hartz AMS; Taylor CE; McCulloch SD; Thalman SW; Xia M; McCarty K; Ubele M; Head E; Hyder F; Sanganahalli BG
Neurobiol Dis; 2020 Jun; 139():104834. PubMed ID: 32173556
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice.
Maldonado Weng J; Parikh I; Naqib A; York J; Green SJ; Estus S; LaDu MJ
Mol Neurodegener; 2019 Dec; 14(1):47. PubMed ID: 31861986
[TBL] [Abstract][Full Text] [Related]
11. Obesity Accelerates Alzheimer-Related Pathology in
Moser VA; Pike CJ
eNeuro; 2017; 4(3):. PubMed ID: 28612048
[TBL] [Abstract][Full Text] [Related]
12. Estradiol improves behavior in FAD transgenic mice that express
Balu D; Valencia-Olvera AC; Deshpande A; Narayanam S; Konasani S; Pattisapu S; York JM; Thatcher GRJ; LaDu MJ; Tai LM
Front Endocrinol (Lausanne); 2024; 15():1374825. PubMed ID: 38742194
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
15. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain.
Teter B; LaDu MJ; Sullivan PM; Frautschy SA; Cole GM
Neuroreport; 2016 Aug; 27(11):791-5. PubMed ID: 27281274
[TBL] [Abstract][Full Text] [Related]
18. APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice.
Zhou M; Huang T; Collins N; Zhang J; Shen H; Dai X; Xiao N; Wu X; Wei Z; York J; Lin L; Zhu Y; LaDu MJ; Chen X
Curr Alzheimer Res; 2016; 13(9):1048-55. PubMed ID: 27087442
[TBL] [Abstract][Full Text] [Related]
19. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
[TBL] [Abstract][Full Text] [Related]
20. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
